Showing results (1-10 of 4,149) with videos related to
Sort By:
Pageof 415
Journal for Immunotherapy of Cancer|June 10, 2022
Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expressionTingting Lv, Xiaofeng Xiong, Wei Yan, et al.Journal for Immunotherapy of Cancer|June 10, 2022
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activityAlexander Muik, Homer C Adams 3rd, Friederike Gieseke, et al.Journal for Immunotherapy of Cancer|June 10, 2022
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREGCindy Franklin, Peter Mohr, Leonie Bluhm, et al.Journal for Immunotherapy of Cancer|April 25, 2019
Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker featuresJonathan D Schoenfeld, Mizuki Nishino, Mariano Severgnini, et al.Journal for Immunotherapy of Cancer|May 30, 2019
Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinomaPooja Ghatalia, Jennifer Gordetsky, Fengshen Kuo, et al.Journal for Immunotherapy of Cancer|May 31, 2019
Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinationsVidyalakshmi Chandramohan, Xuhui Bao, Xin Yu, et al.Journal for Immunotherapy of Cancer|May 31, 2019
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemiaMelanie Märklin, Ilona Hagelstein, Samuel P Koerner, et al.Journal for Immunotherapy of Cancer|June 9, 2019
Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centersLaura Marconato, Luca Aresu, Damiano Stefanello, et al.Journal for Immunotherapy of Cancer|May 24, 2019
Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptidesHanan Besser, Sharon Yunger, Efrat Merhavi-Shoham, et al.Journal for Immunotherapy of Cancer|June 22, 2019
Tumor-associated macrophage expression of interferon regulatory Factor-8 (IRF8) is a predictor of progression and patient survival in renal cell carcinomaJason B Muhitch, Nicholas C Hoffend, Gissou Azabdaftari, et al.Pageof 415